↓ Skip to main content

CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and…

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, October 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#14 of 930)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
8 news outlets
blogs
2 blogs
twitter
232 X users
facebook
2 Facebook pages
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
140 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria
Published in
Allergy, Asthma & Clinical Immunology, October 2019
DOI 10.1186/s13223-019-0375-9
Pubmed ID
Authors

Michael N. Fein, David A. Fischer, Andrew W. O’Keefe, Gord L. Sussman

X Demographics

X Demographics

The data shown below were collected from the profiles of 232 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 140 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 12%
Other 12 9%
Researcher 9 6%
Student > Postgraduate 9 6%
Student > Master 9 6%
Other 24 17%
Unknown 60 43%
Readers by discipline Count As %
Medicine and Dentistry 32 23%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Nursing and Health Professions 9 6%
Biochemistry, Genetics and Molecular Biology 8 6%
Immunology and Microbiology 3 2%
Other 12 9%
Unknown 66 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 249. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2024.
All research outputs
#152,440
of 25,789,020 outputs
Outputs from Allergy, Asthma & Clinical Immunology
#14
of 930 outputs
Outputs of similar age
#3,013
of 364,176 outputs
Outputs of similar age from Allergy, Asthma & Clinical Immunology
#1
of 20 outputs
Altmetric has tracked 25,789,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 930 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,176 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.